Rank | Gene Set | Z-score |
---|---|---|
1 | inositol phosphate catabolic process (GO:0071545) | 5.67466868 |
2 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 5.65952491 |
3 | inositol phosphate dephosphorylation (GO:0046855) | 5.65952491 |
4 | negative regulation of dendrite morphogenesis (GO:0050774) | 5.64563149 |
5 | ER overload response (GO:0006983) | 5.51003088 |
6 | presynaptic membrane assembly (GO:0097105) | 5.20062234 |
7 | neural tube formation (GO:0001841) | 4.65738983 |
8 | snRNA transcription (GO:0009301) | 4.55384667 |
9 | limb bud formation (GO:0060174) | 4.36973965 |
10 | presynaptic membrane organization (GO:0097090) | 4.28780290 |
11 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.12888504 |
12 | prostate gland growth (GO:0060736) | 3.83750753 |
13 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.78848885 |
14 | protein localization to cilium (GO:0061512) | 3.55741679 |
15 | nucleobase catabolic process (GO:0046113) | 3.51951599 |
16 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.45893600 |
17 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.45893600 |
18 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.45893600 |
19 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.41911123 |
20 | negative regulation of dendrite development (GO:2000171) | 3.40287243 |
21 | cilium morphogenesis (GO:0060271) | 3.38124316 |
22 | polyol catabolic process (GO:0046174) | 3.37882856 |
23 | phosphatidylinositol dephosphorylation (GO:0046856) | 3.33614841 |
24 | protein prenylation (GO:0018342) | 3.33303555 |
25 | prenylation (GO:0097354) | 3.33303555 |
26 | neutrophil activation involved in immune response (GO:0002283) | 3.32263589 |
27 | negative regulation of neurotransmitter transport (GO:0051589) | 3.29209645 |
28 | photoreceptor cell differentiation (GO:0046530) | 3.21491042 |
29 | eye photoreceptor cell differentiation (GO:0001754) | 3.21491042 |
30 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.20444070 |
31 | DNA double-strand break processing (GO:0000729) | 3.18578026 |
32 | regulation of cilium movement (GO:0003352) | 3.17306789 |
33 | epithelial cilium movement (GO:0003351) | 3.11882550 |
34 | regulation of glucokinase activity (GO:0033131) | 3.10606314 |
35 | regulation of hexokinase activity (GO:1903299) | 3.10606314 |
36 | glycosphingolipid biosynthetic process (GO:0006688) | 3.10294620 |
37 | neuron cell-cell adhesion (GO:0007158) | 3.09918243 |
38 | kidney morphogenesis (GO:0060993) | 3.07738114 |
39 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.06780166 |
40 | regulation of protein polyubiquitination (GO:1902914) | 3.05899890 |
41 | retinal ganglion cell axon guidance (GO:0031290) | 3.05437745 |
42 | cilium organization (GO:0044782) | 3.05057336 |
43 | dendritic spine morphogenesis (GO:0060997) | 3.02400934 |
44 | olfactory bulb development (GO:0021772) | 3.02260325 |
45 | signal peptide processing (GO:0006465) | 3.00883350 |
46 | cilium assembly (GO:0042384) | 3.00217653 |
47 | regulation of pigment cell differentiation (GO:0050932) | 2.96590423 |
48 | intraciliary transport (GO:0042073) | 2.96081722 |
49 | regulation of RIG-I signaling pathway (GO:0039535) | 2.95753148 |
50 | L-fucose catabolic process (GO:0042355) | 2.94564923 |
51 | fucose catabolic process (GO:0019317) | 2.94564923 |
52 | L-fucose metabolic process (GO:0042354) | 2.94564923 |
53 | phospholipid dephosphorylation (GO:0046839) | 2.94229657 |
54 | somite development (GO:0061053) | 2.91378927 |
55 | maternal behavior (GO:0042711) | 2.89866726 |
56 | cornea development in camera-type eye (GO:0061303) | 2.89135259 |
57 | neuron fate determination (GO:0048664) | 2.88464762 |
58 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.88042432 |
59 | urinary tract smooth muscle contraction (GO:0014848) | 2.87044364 |
60 | axoneme assembly (GO:0035082) | 2.86979807 |
61 | establishment of protein localization to Golgi (GO:0072600) | 2.86279906 |
62 | parental behavior (GO:0060746) | 2.86220088 |
63 | photoreceptor cell maintenance (GO:0045494) | 2.85786671 |
64 | intracellular pH reduction (GO:0051452) | 2.84395856 |
65 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.84284220 |
66 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.84284220 |
67 | response to pheromone (GO:0019236) | 2.84179652 |
68 | regulation of feeding behavior (GO:0060259) | 2.83431779 |
69 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.83396355 |
70 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.81281315 |
71 | regulation of telomere maintenance (GO:0032204) | 2.81230468 |
72 | negative regulation of phagocytosis (GO:0050765) | 2.78914069 |
73 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.77199818 |
74 | retinal cone cell development (GO:0046549) | 2.76603657 |
75 | cellular response to prostaglandin stimulus (GO:0071379) | 2.76291146 |
76 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.75995473 |
77 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.75590036 |
78 | synaptic vesicle exocytosis (GO:0016079) | 2.75407667 |
79 | platelet dense granule organization (GO:0060155) | 2.75153223 |
80 | multicellular organismal reproductive behavior (GO:0033057) | 2.74525817 |
81 | protein targeting to Golgi (GO:0000042) | 2.74389999 |
82 | gamma-aminobutyric acid transport (GO:0015812) | 2.74351052 |
83 | negative regulation of membrane potential (GO:0045837) | 2.73505562 |
84 | embryonic epithelial tube formation (GO:0001838) | 2.72198082 |
85 | cullin deneddylation (GO:0010388) | 2.70696083 |
86 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.70506231 |
87 | cellular response to gamma radiation (GO:0071480) | 2.68693097 |
88 | glial cell proliferation (GO:0014009) | 2.67364101 |
89 | central nervous system neuron axonogenesis (GO:0021955) | 2.66477334 |
90 | keratinocyte development (GO:0003334) | 2.65809603 |
91 | dentate gyrus development (GO:0021542) | 2.65324087 |
92 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.65295826 |
93 | phagosome maturation (GO:0090382) | 2.61357677 |
94 | regulation of collateral sprouting (GO:0048670) | 2.61019536 |
95 | establishment of melanosome localization (GO:0032401) | 2.60555697 |
96 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.59656913 |
97 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.59193017 |
98 | cilium movement (GO:0003341) | 2.59070163 |
99 | positive regulation of microtubule polymerization (GO:0031116) | 2.58255564 |
100 | lactate metabolic process (GO:0006089) | 2.58149900 |
101 | behavioral response to ethanol (GO:0048149) | 2.57713276 |
102 | long-term synaptic potentiation (GO:0060291) | 2.56539300 |
103 | establishment of pigment granule localization (GO:0051905) | 2.55459330 |
104 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.54687121 |
105 | axonal fasciculation (GO:0007413) | 2.54669442 |
106 | regulation of timing of cell differentiation (GO:0048505) | 2.52597591 |
107 | T-helper cell differentiation (GO:0042093) | 2.51869078 |
108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.51869078 |
109 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.50894918 |
110 | activated T cell proliferation (GO:0050798) | 2.50822435 |
111 | histone H2A acetylation (GO:0043968) | 2.50262419 |
112 | epithelial tube formation (GO:0072175) | 2.49612156 |
113 | neutrophil activation (GO:0042119) | 2.49604538 |
114 | protein localization to Golgi apparatus (GO:0034067) | 2.49207834 |
115 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.48858888 |
116 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.48347154 |
117 | serotonin metabolic process (GO:0042428) | 2.48110490 |
118 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.48058386 |
119 | negative regulation of exocytosis (GO:0045920) | 2.47808061 |
120 | regulation of metalloenzyme activity (GO:0048552) | 2.46958057 |
121 | photoreceptor cell development (GO:0042461) | 2.46802111 |
122 | glycerophospholipid catabolic process (GO:0046475) | 2.46770634 |
123 | positive regulation of amino acid transport (GO:0051957) | 2.46237496 |
124 | protein K11-linked deubiquitination (GO:0035871) | 2.46154374 |
125 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.46007788 |
126 | negative regulation of axon guidance (GO:1902668) | 2.45348362 |
127 | melanosome transport (GO:0032402) | 2.45133545 |
128 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 2.45034688 |
129 | negative regulation of neurological system process (GO:0031645) | 2.44786185 |
130 | mannosylation (GO:0097502) | 2.44606060 |
131 | appendage development (GO:0048736) | 2.44394007 |
132 | limb development (GO:0060173) | 2.44394007 |
133 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.43826597 |
134 | somite rostral/caudal axis specification (GO:0032525) | 2.43729013 |
135 | pH reduction (GO:0045851) | 2.43634336 |
136 | dendrite development (GO:0016358) | 2.43615633 |
137 | GPI anchor metabolic process (GO:0006505) | 2.43480208 |
138 | inner ear receptor stereocilium organization (GO:0060122) | 2.43345541 |
139 | autophagic vacuole fusion (GO:0000046) | 2.41724253 |
140 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.41700159 |
141 | DNA integration (GO:0015074) | 2.41554142 |
142 | transferrin transport (GO:0033572) | 2.41336325 |
143 | pigment granule transport (GO:0051904) | 2.40528883 |
144 | C-terminal protein amino acid modification (GO:0018410) | 2.40242706 |
145 | negative regulation of protein oligomerization (GO:0032460) | 2.39999769 |
146 | resolution of meiotic recombination intermediates (GO:0000712) | 2.39610414 |
147 | branched-chain amino acid catabolic process (GO:0009083) | 2.39344695 |
148 | cellular ketone body metabolic process (GO:0046950) | 2.39309920 |
149 | regulation of development, heterochronic (GO:0040034) | 2.39258382 |
150 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.38995117 |
151 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.38995117 |
152 | protein deneddylation (GO:0000338) | 2.38874086 |
153 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.38161986 |
154 | protein neddylation (GO:0045116) | 2.37539212 |
155 | replication fork processing (GO:0031297) | 2.37538625 |
156 | regulation of heat generation (GO:0031650) | 2.36920188 |
157 | synapse assembly (GO:0007416) | 2.36816038 |
158 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.36313882 |
159 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.36310737 |
160 | C-terminal protein lipidation (GO:0006501) | 2.35758717 |
161 | hindbrain development (GO:0030902) | 2.35089095 |
162 | positive regulation of mitochondrial fission (GO:0090141) | 2.33792263 |
163 | megakaryocyte development (GO:0035855) | 2.33059321 |
164 | cellular response to interferon-beta (GO:0035458) | 2.31918685 |
165 | granulocyte activation (GO:0036230) | 2.31792994 |
166 | postsynaptic membrane organization (GO:0001941) | 2.31597336 |
167 | nerve growth factor signaling pathway (GO:0038180) | 2.31303493 |
168 | negative regulation of B cell mediated immunity (GO:0002713) | 2.31248313 |
169 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.31248313 |
170 | nonmotile primary cilium assembly (GO:0035058) | 2.28794794 |
171 | positive regulation of developmental pigmentation (GO:0048087) | 2.28483826 |
172 | parturition (GO:0007567) | 2.28195035 |
173 | viral protein processing (GO:0019082) | 2.26396474 |
174 | negative regulation of mast cell activation (GO:0033004) | 2.26218761 |
175 | startle response (GO:0001964) | 2.25524860 |
176 | regulation of oxidative phosphorylation (GO:0002082) | 2.23576884 |
177 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.22519674 |
178 | membrane assembly (GO:0071709) | 2.22413141 |
179 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.21986672 |
180 | myelin maintenance (GO:0043217) | 2.21597344 |
181 | anterograde synaptic vesicle transport (GO:0048490) | 2.20538934 |
182 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.19177899 |
183 | cellular response to interleukin-15 (GO:0071350) | 2.18538906 |
184 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.16879253 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.91007540 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.67198228 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.47770242 |
4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.41522551 |
5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.34782228 |
6 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.29331219 |
7 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.86440428 |
8 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.78049480 |
9 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.75747939 |
10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.68801608 |
11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.57294868 |
12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.40455929 |
13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.35504727 |
14 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.12014581 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.09140580 |
16 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.00249457 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.91986846 |
18 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.90587276 |
19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.86237927 |
20 | P300_19829295_ChIP-Seq_ESCs_Human | 1.84922373 |
21 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.82556960 |
22 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.78435784 |
23 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.71190365 |
24 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70853048 |
25 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.65088772 |
26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.64377017 |
27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64003151 |
28 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61116899 |
29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60580963 |
30 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56985709 |
31 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.56858053 |
32 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.56109576 |
33 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.54682838 |
34 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.53715517 |
35 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.53588392 |
36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.53162757 |
37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.52954722 |
38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.52398519 |
39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52386670 |
40 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.52364533 |
41 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.47555650 |
42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.47138545 |
43 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.46360832 |
44 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46050256 |
45 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.45699589 |
46 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.45603176 |
47 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.45423977 |
48 | VDR_22108803_ChIP-Seq_LS180_Human | 1.45165673 |
49 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.44992351 |
50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.42989631 |
51 | TCF4_23295773_ChIP-Seq_U87_Human | 1.42611428 |
52 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.40309615 |
53 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39582212 |
54 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.39316619 |
55 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38822912 |
56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34607311 |
57 | AR_25329375_ChIP-Seq_VCAP_Human | 1.32735275 |
58 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32704329 |
59 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.32441727 |
60 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.31084189 |
61 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30963329 |
62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29295272 |
63 | KDM2B_26808549_Chip-Seq_REH_Human | 1.27437017 |
64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.27296112 |
65 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27134587 |
66 | EWS_26573619_Chip-Seq_HEK293_Human | 1.27085261 |
67 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.26285537 |
68 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.25904003 |
69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.25371638 |
70 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.25289154 |
71 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25141081 |
72 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.24997697 |
73 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.24308584 |
74 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22915831 |
75 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22902768 |
76 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.22897285 |
77 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.21375803 |
78 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.21087408 |
79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21046246 |
80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21046246 |
81 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20718745 |
82 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20718745 |
83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.19314012 |
84 | STAT3_23295773_ChIP-Seq_U87_Human | 1.19059936 |
85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.18888634 |
86 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.18113833 |
87 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.17955921 |
88 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.16836983 |
89 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.16572482 |
90 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16088261 |
91 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.14534498 |
92 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.13374381 |
93 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10883134 |
94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10540640 |
95 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.10325058 |
96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09266483 |
97 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.07766212 |
98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07574001 |
99 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06903310 |
100 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.06839673 |
101 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.06677819 |
102 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06539559 |
103 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.06298698 |
104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.05566513 |
105 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05377341 |
106 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05179516 |
107 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04866827 |
108 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.04473073 |
109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04230127 |
110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03139396 |
111 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03098810 |
112 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.03008876 |
113 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.01468143 |
114 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.00842903 |
115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00496397 |
116 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.99978727 |
117 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99866207 |
118 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99816421 |
119 | JUN_21703547_ChIP-Seq_K562_Human | 0.98788176 |
120 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.98712863 |
121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.97603185 |
122 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.97009626 |
123 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96056257 |
124 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96056257 |
125 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.95503978 |
126 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95047062 |
127 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.94486157 |
128 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93397537 |
129 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93089329 |
130 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.92509934 |
131 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92480280 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0000372_irregular_coat_pigmentation | 4.23300262 |
2 | MP0005171_absent_coat_pigmentation | 4.10540144 |
3 | MP0003183_abnormal_peptide_metabolism | 2.94198708 |
4 | MP0003787_abnormal_imprinting | 2.91795940 |
5 | MP0009697_abnormal_copulation | 2.81313448 |
6 | MP0000569_abnormal_digit_pigmentation | 2.79881179 |
7 | MP0003880_abnormal_central_pattern | 2.75477947 |
8 | MP0001984_abnormal_olfaction | 2.48690434 |
9 | MP0010234_abnormal_vibrissa_follicle | 2.38395919 |
10 | MP0006276_abnormal_autonomic_nervous | 2.26712045 |
11 | MP0006072_abnormal_retinal_apoptosis | 2.24627063 |
12 | MP0004270_analgesia | 2.18429257 |
13 | MP0008789_abnormal_olfactory_epithelium | 2.15386741 |
14 | MP0003122_maternal_imprinting | 2.11558742 |
15 | MP0004859_abnormal_synaptic_plasticity | 2.08119170 |
16 | MP0005409_darkened_coat_color | 2.05083476 |
17 | MP0005645_abnormal_hypothalamus_physiol | 1.99407683 |
18 | MP0005253_abnormal_eye_physiology | 1.98461375 |
19 | MP0005671_abnormal_response_to | 1.93364839 |
20 | MP0005551_abnormal_eye_electrophysiolog | 1.90810844 |
21 | MP0002734_abnormal_mechanical_nocicepti | 1.85574976 |
22 | MP0005499_abnormal_olfactory_system | 1.85444863 |
23 | MP0005394_taste/olfaction_phenotype | 1.85444863 |
24 | MP0002751_abnormal_autonomic_nervous | 1.78081107 |
25 | MP0003890_abnormal_embryonic-extraembry | 1.76144518 |
26 | MP0003011_delayed_dark_adaptation | 1.73040252 |
27 | MP0000015_abnormal_ear_pigmentation | 1.72515709 |
28 | MP0002160_abnormal_reproductive_system | 1.72176444 |
29 | MP0001905_abnormal_dopamine_level | 1.71211044 |
30 | MP0005646_abnormal_pituitary_gland | 1.70820048 |
31 | MP0005367_renal/urinary_system_phenotyp | 1.69373207 |
32 | MP0000516_abnormal_urinary_system | 1.69373207 |
33 | MP0008057_abnormal_DNA_replication | 1.67338041 |
34 | MP0002736_abnormal_nociception_after | 1.66885936 |
35 | MP0003195_calcinosis | 1.65692601 |
36 | MP0002938_white_spotting | 1.65152048 |
37 | MP0006292_abnormal_olfactory_placode | 1.64583363 |
38 | MP0004742_abnormal_vestibular_system | 1.62814694 |
39 | MP0001968_abnormal_touch/_nociception | 1.61891864 |
40 | MP0010386_abnormal_urinary_bladder | 1.59464193 |
41 | MP0003635_abnormal_synaptic_transmissio | 1.57523615 |
42 | MP0009046_muscle_twitch | 1.57112340 |
43 | MP0000778_abnormal_nervous_system | 1.55885411 |
44 | MP0002876_abnormal_thyroid_physiology | 1.51778866 |
45 | MP0002822_catalepsy | 1.50158093 |
46 | MP0002064_seizures | 1.49546407 |
47 | MP0001529_abnormal_vocalization | 1.49487021 |
48 | MP0008058_abnormal_DNA_repair | 1.45884620 |
49 | MP0000631_abnormal_neuroendocrine_gland | 1.44994772 |
50 | MP0000681_abnormal_thyroid_gland | 1.44902020 |
51 | MP0004133_heterotaxia | 1.43623962 |
52 | MP0009780_abnormal_chondrocyte_physiolo | 1.43385049 |
53 | MP0008877_abnormal_DNA_methylation | 1.42586489 |
54 | MP0002234_abnormal_pharynx_morphology | 1.41866679 |
55 | MP0002837_dystrophic_cardiac_calcinosis | 1.39417182 |
56 | MP0009745_abnormal_behavioral_response | 1.37907178 |
57 | MP0002272_abnormal_nervous_system | 1.37469144 |
58 | MP0002572_abnormal_emotion/affect_behav | 1.36686995 |
59 | MP0002735_abnormal_chemical_nociception | 1.35379008 |
60 | MP0002928_abnormal_bile_duct | 1.35245423 |
61 | MP0004924_abnormal_behavior | 1.33426565 |
62 | MP0005386_behavior/neurological_phenoty | 1.33426565 |
63 | MP0005248_abnormal_Harderian_gland | 1.33021660 |
64 | MP0002063_abnormal_learning/memory/cond | 1.32208681 |
65 | MP0000920_abnormal_myelination | 1.30459616 |
66 | MP0005379_endocrine/exocrine_gland_phen | 1.29914493 |
67 | MP0005387_immune_system_phenotype | 1.29665237 |
68 | MP0001790_abnormal_immune_system | 1.29665237 |
69 | MP0001800_abnormal_humoral_immune | 1.29057982 |
70 | MP0002638_abnormal_pupillary_reflex | 1.28758226 |
71 | MP0005187_abnormal_penis_morphology | 1.27123424 |
72 | MP0000383_abnormal_hair_follicle | 1.24916798 |
73 | MP0002148_abnormal_hypersensitivity_rea | 1.24380231 |
74 | MP0008995_early_reproductive_senescence | 1.24165066 |
75 | MP0005000_abnormal_immune_tolerance | 1.23800843 |
76 | MP0001835_abnormal_antigen_presentation | 1.23042989 |
77 | MP0005397_hematopoietic_system_phenotyp | 1.21989358 |
78 | MP0001545_abnormal_hematopoietic_system | 1.21989358 |
79 | MP0000647_abnormal_sebaceous_gland | 1.20431371 |
80 | MP0010678_abnormal_skin_adnexa | 1.20057140 |
81 | MP0002067_abnormal_sensory_capabilities | 1.19647040 |
82 | MP0003136_yellow_coat_color | 1.18344664 |
83 | MP0004215_abnormal_myocardial_fiber | 1.14399054 |
84 | MP0001486_abnormal_startle_reflex | 1.14276016 |
85 | MP0002277_abnormal_respiratory_mucosa | 1.13728930 |
86 | MP0002233_abnormal_nose_morphology | 1.13638383 |
87 | MP0003763_abnormal_thymus_physiology | 1.12434290 |
88 | MP0002452_abnormal_antigen_presenting | 1.12076149 |
89 | MP0003718_maternal_effect | 1.11939334 |
90 | MP0005084_abnormal_gallbladder_morpholo | 1.11371472 |
91 | MP0001986_abnormal_taste_sensitivity | 1.10118917 |
92 | MP0002933_joint_inflammation | 1.09420680 |
93 | MP0002723_abnormal_immune_serum | 1.09323963 |
94 | MP0002419_abnormal_innate_immunity | 1.08196172 |
95 | MP0002420_abnormal_adaptive_immunity | 1.07967699 |
96 | MP0009785_altered_susceptibility_to | 1.07482499 |
97 | MP0001819_abnormal_immune_cell | 1.06719014 |
98 | MP0003119_abnormal_digestive_system | 1.06674489 |
99 | MP0000685_abnormal_immune_system | 1.03605168 |
100 | MP0004885_abnormal_endolymph | 1.03432393 |
101 | MP0004142_abnormal_muscle_tone | 1.03054456 |
102 | MP0001485_abnormal_pinna_reflex | 1.02647764 |
103 | MP0002229_neurodegeneration | 0.99962468 |
104 | MP0001188_hyperpigmentation | 0.99825787 |
105 | MP0001293_anophthalmia | 0.98821808 |
106 | MP0002557_abnormal_social/conspecific_i | 0.95393150 |
107 | MP0001970_abnormal_pain_threshold | 0.95252055 |
108 | MP0002752_abnormal_somatic_nervous | 0.95036766 |
109 | MP0005389_reproductive_system_phenotype | 0.94774405 |
110 | MP0002090_abnormal_vision | 0.94201904 |
111 | MP0003724_increased_susceptibility_to | 0.94176666 |
112 | MP0003634_abnormal_glial_cell | 0.93944773 |
113 | MP0005075_abnormal_melanosome_morpholog | 0.92828502 |
114 | MP0003121_genomic_imprinting | 0.92297809 |
115 | MP0005310_abnormal_salivary_gland | 0.91948661 |
116 | MP0000427_abnormal_hair_cycle | 0.91618202 |
117 | MP0010352_gastrointestinal_tract_polyps | 0.91245816 |
118 | MP0005195_abnormal_posterior_eye | 0.91010769 |
119 | MP0002102_abnormal_ear_morphology | 0.90982876 |
120 | MP0005391_vision/eye_phenotype | 0.90433840 |
121 | MP0005174_abnormal_tail_pigmentation | 0.90167701 |
122 | MP0002184_abnormal_innervation | 0.89921459 |
123 | MP0000955_abnormal_spinal_cord | 0.89618679 |
124 | MP0002163_abnormal_gland_morphology | 0.89368436 |
125 | MP0004043_abnormal_pH_regulation | 0.89079412 |
126 | MP0002653_abnormal_ependyma_morphology | 0.88682288 |
127 | MP0009333_abnormal_splenocyte_physiolog | 0.88144348 |
128 | MP0003937_abnormal_limbs/digits/tail_de | 0.87460076 |
129 | MP0003755_abnormal_palate_morphology | 0.86508901 |
130 | MP0002095_abnormal_skin_pigmentation | 0.86503928 |
131 | MP0008872_abnormal_physiological_respon | 0.86225394 |
132 | MP0001501_abnormal_sleep_pattern | 0.85065978 |
133 | MP0002909_abnormal_adrenal_gland | 0.83992140 |
134 | MP0003690_abnormal_glial_cell | 0.83752912 |
135 | MP0002882_abnormal_neuron_morphology | 0.83638150 |
136 | MP0002398_abnormal_bone_marrow | 0.82748488 |
137 | MP0005025_abnormal_response_to | 0.81883983 |
138 | MP0005410_abnormal_fertilization | 0.80791617 |
139 | MP0001440_abnormal_grooming_behavior | 0.79381624 |
140 | MP0004782_abnormal_surfactant_physiolog | 0.79374511 |
141 | MP0000716_abnormal_immune_system | 0.79075947 |
142 | MP0001851_eye_inflammation | 0.77741665 |
143 | MP0001324_abnormal_eye_pigmentation | 0.76931633 |
144 | MP0003283_abnormal_digestive_organ | 0.76831680 |
145 | MP0000026_abnormal_inner_ear | 0.76553768 |
146 | MP0006054_spinal_hemorrhage | 0.76233635 |
147 | MP0003786_premature_aging | 0.76012837 |
148 | MP0003631_nervous_system_phenotype | 0.75339915 |
149 | MP0002006_tumorigenesis | 0.75145439 |
150 | MP0002069_abnormal_eating/drinking_beha | 0.74402587 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypothermia (HP:0002045) | 7.17972154 |
2 | Thyroiditis (HP:0100646) | 3.86145830 |
3 | Pancreatic fibrosis (HP:0100732) | 3.59731899 |
4 | Medial flaring of the eyebrow (HP:0010747) | 3.58224149 |
5 | Arterial tortuosity (HP:0005116) | 3.45366627 |
6 | Gait imbalance (HP:0002141) | 3.45031714 |
7 | Abnormal hair whorl (HP:0010721) | 3.34842844 |
8 | Congenital primary aphakia (HP:0007707) | 3.31437461 |
9 | Neoplasm of the adrenal cortex (HP:0100641) | 3.31226175 |
10 | Intestinal atresia (HP:0011100) | 3.25383628 |
11 | Asymmetry of the thorax (HP:0001555) | 3.22102720 |
12 | Nephrogenic diabetes insipidus (HP:0009806) | 3.09238505 |
13 | Abnormality of cochlea (HP:0000375) | 3.03372025 |
14 | Thyroid carcinoma (HP:0002890) | 3.02764958 |
15 | True hermaphroditism (HP:0010459) | 3.01851489 |
16 | Renal cortical cysts (HP:0000803) | 2.97845250 |
17 | Abnormality of the renal cortex (HP:0011035) | 2.94136126 |
18 | Amblyopia (HP:0000646) | 2.88052904 |
19 | Methylmalonic acidemia (HP:0002912) | 2.83786136 |
20 | Orthostatic hypotension (HP:0001278) | 2.82316903 |
21 | Vascular tortuosity (HP:0004948) | 2.80368169 |
22 | Chronic hepatic failure (HP:0100626) | 2.80096619 |
23 | Volvulus (HP:0002580) | 2.76855508 |
24 | Abnormality of the labia minora (HP:0012880) | 2.75722194 |
25 | Progressive inability to walk (HP:0002505) | 2.73812190 |
26 | Abnormality of midbrain morphology (HP:0002418) | 2.69533834 |
27 | Molar tooth sign on MRI (HP:0002419) | 2.69533834 |
28 | Poor coordination (HP:0002370) | 2.62884361 |
29 | Vaginal atresia (HP:0000148) | 2.62851548 |
30 | Papillary thyroid carcinoma (HP:0002895) | 2.61786928 |
31 | Retinal dysplasia (HP:0007973) | 2.60378308 |
32 | Chronic diarrhea (HP:0002028) | 2.58625987 |
33 | Genital tract atresia (HP:0001827) | 2.56446783 |
34 | Hematochezia (HP:0002573) | 2.56078468 |
35 | Febrile seizures (HP:0002373) | 2.47591621 |
36 | Large for gestational age (HP:0001520) | 2.46821398 |
37 | Hemiparesis (HP:0001269) | 2.40459981 |
38 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.40196560 |
39 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.40196560 |
40 | Morphological abnormality of the inner ear (HP:0011390) | 2.37514929 |
41 | Absent speech (HP:0001344) | 2.35189076 |
42 | Abnormality of incisor morphology (HP:0011063) | 2.35001319 |
43 | Aqueductal stenosis (HP:0002410) | 2.34451706 |
44 | Progressive macrocephaly (HP:0004481) | 2.33060061 |
45 | Lissencephaly (HP:0001339) | 2.32816112 |
46 | Hyperthyroidism (HP:0000836) | 2.30712573 |
47 | Neuroendocrine neoplasm (HP:0100634) | 2.28742836 |
48 | Pancreatic cysts (HP:0001737) | 2.28222963 |
49 | Type II lissencephaly (HP:0007260) | 2.27240368 |
50 | Heterochromia iridis (HP:0001100) | 2.27040462 |
51 | Recurrent abscess formation (HP:0002722) | 2.23876424 |
52 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.23798627 |
53 | Oligodactyly (hands) (HP:0001180) | 2.20660607 |
54 | Optic nerve hypoplasia (HP:0000609) | 2.17863663 |
55 | Polyphagia (HP:0002591) | 2.17282769 |
56 | Atonic seizures (HP:0010819) | 2.15655241 |
57 | Sensory axonal neuropathy (HP:0003390) | 2.14098528 |
58 | Spinal muscular atrophy (HP:0007269) | 2.13682867 |
59 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.13472199 |
60 | Poor speech (HP:0002465) | 2.13356542 |
61 | Stenosis of the external auditory canal (HP:0000402) | 2.13065682 |
62 | Abnormality of T cell number (HP:0011839) | 2.11451945 |
63 | T lymphocytopenia (HP:0005403) | 2.09417935 |
64 | Abnormality of the fingertips (HP:0001211) | 2.08352038 |
65 | Narrow forehead (HP:0000341) | 2.08204476 |
66 | Epileptic encephalopathy (HP:0200134) | 2.06780376 |
67 | Abolished electroretinogram (ERG) (HP:0000550) | 2.05934538 |
68 | Macroorchidism (HP:0000053) | 2.03462464 |
69 | Gaze-evoked nystagmus (HP:0000640) | 2.03027776 |
70 | Abnormality of the metopic suture (HP:0005556) | 2.02803261 |
71 | Short tibia (HP:0005736) | 2.01440294 |
72 | Attenuation of retinal blood vessels (HP:0007843) | 2.01026016 |
73 | Nephronophthisis (HP:0000090) | 1.99783097 |
74 | Methylmalonic aciduria (HP:0012120) | 1.99511665 |
75 | Pheochromocytoma (HP:0002666) | 1.99208166 |
76 | Broad foot (HP:0001769) | 1.97019631 |
77 | Focal motor seizures (HP:0011153) | 1.96988184 |
78 | Conjunctival hamartoma (HP:0100780) | 1.96759870 |
79 | Mask-like facies (HP:0000298) | 1.95595433 |
80 | Broad-based gait (HP:0002136) | 1.95518829 |
81 | Bile duct proliferation (HP:0001408) | 1.94879674 |
82 | Abnormal biliary tract physiology (HP:0012439) | 1.94879674 |
83 | Ketoacidosis (HP:0001993) | 1.93495862 |
84 | Gastrointestinal atresia (HP:0002589) | 1.92987144 |
85 | Septo-optic dysplasia (HP:0100842) | 1.92884032 |
86 | Abnormality of vitamin B metabolism (HP:0004340) | 1.92568207 |
87 | Flat capital femoral epiphysis (HP:0003370) | 1.92437299 |
88 | Akinesia (HP:0002304) | 1.92228410 |
89 | Hypsarrhythmia (HP:0002521) | 1.91743760 |
90 | Hyperventilation (HP:0002883) | 1.91433859 |
91 | Progressive cerebellar ataxia (HP:0002073) | 1.91177997 |
92 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.90591806 |
93 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90301921 |
94 | 3-Methylglutaconic aciduria (HP:0003535) | 1.89663514 |
95 | Spontaneous hematomas (HP:0007420) | 1.89590763 |
96 | Excessive salivation (HP:0003781) | 1.88016948 |
97 | Drooling (HP:0002307) | 1.88016948 |
98 | Cystic liver disease (HP:0006706) | 1.87940854 |
99 | Congenital stationary night blindness (HP:0007642) | 1.87698914 |
100 | Cutaneous melanoma (HP:0012056) | 1.86763850 |
101 | EEG with generalized epileptiform discharges (HP:0011198) | 1.86135217 |
102 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.86003601 |
103 | Hypoplasia of the fovea (HP:0007750) | 1.86003601 |
104 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.85933728 |
105 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.85879539 |
106 | Decreased lacrimation (HP:0000633) | 1.85649746 |
107 | IgM deficiency (HP:0002850) | 1.85508833 |
108 | Tubulointerstitial nephritis (HP:0001970) | 1.85369972 |
109 | Vasculitis (HP:0002633) | 1.85170072 |
110 | Decreased testicular size (HP:0008734) | 1.83663096 |
111 | Keratoconus (HP:0000563) | 1.82782559 |
112 | Increased corneal curvature (HP:0100692) | 1.82782559 |
113 | Recurrent bacterial skin infections (HP:0005406) | 1.82647465 |
114 | Furrowed tongue (HP:0000221) | 1.82356328 |
115 | Tinnitus (HP:0000360) | 1.82293266 |
116 | Epileptiform EEG discharges (HP:0011182) | 1.82063140 |
117 | Fair hair (HP:0002286) | 1.81844167 |
118 | Congenital hepatic fibrosis (HP:0002612) | 1.81287604 |
119 | Abnormal autonomic nervous system physiology (HP:0012332) | 1.80515571 |
120 | Occipital encephalocele (HP:0002085) | 1.79866694 |
121 | Anencephaly (HP:0002323) | 1.79533500 |
122 | Autoamputation (HP:0001218) | 1.78765113 |
123 | Hepatoblastoma (HP:0002884) | 1.78482758 |
124 | Prominent nasal bridge (HP:0000426) | 1.78258444 |
125 | Tented upper lip vermilion (HP:0010804) | 1.78242145 |
126 | Bifid tongue (HP:0010297) | 1.78209052 |
127 | Intention tremor (HP:0002080) | 1.77680433 |
128 | Focal seizures (HP:0007359) | 1.77625756 |
129 | Hypoglycemic coma (HP:0001325) | 1.76340585 |
130 | Cupped ear (HP:0000378) | 1.76258584 |
131 | Abnormality of the renal collecting system (HP:0004742) | 1.76257995 |
132 | Neoplasm of the adrenal gland (HP:0100631) | 1.76006269 |
133 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.75533620 |
134 | Arterial thrombosis (HP:0004420) | 1.74467576 |
135 | Oculomotor apraxia (HP:0000657) | 1.73980998 |
136 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.73603026 |
137 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.73603026 |
138 | Delayed closure of the anterior fontanelle (HP:0001476) | 1.73395533 |
139 | Pachygyria (HP:0001302) | 1.72884489 |
140 | Genetic anticipation (HP:0003743) | 1.72857431 |
141 | Agitation (HP:0000713) | 1.72803279 |
142 | Specific learning disability (HP:0001328) | 1.72199739 |
143 | Hyperglycinemia (HP:0002154) | 1.71637506 |
144 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.70767397 |
145 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.70331970 |
146 | Renal hypoplasia (HP:0000089) | 1.69695756 |
147 | Tubular atrophy (HP:0000092) | 1.69563894 |
148 | Delayed gross motor development (HP:0002194) | 1.69141705 |
149 | Generalized myoclonic seizures (HP:0002123) | 1.69118830 |
150 | Widely spaced teeth (HP:0000687) | 1.68955129 |
151 | Sclerocornea (HP:0000647) | 1.68772619 |
152 | Abnormality of the corticospinal tract (HP:0002492) | 1.68754702 |
153 | Abnormality of the renal medulla (HP:0100957) | 1.68739493 |
154 | Type 2 muscle fiber atrophy (HP:0003554) | 1.68342645 |
155 | Inability to walk (HP:0002540) | 1.67426308 |
156 | Alacrima (HP:0000522) | 1.67368050 |
157 | Fetal akinesia sequence (HP:0001989) | 1.66103942 |
158 | Asthma (HP:0002099) | 1.65252953 |
159 | Lip pit (HP:0100267) | 1.63828562 |
160 | Esotropia (HP:0000565) | 1.63693241 |
161 | Nonprogressive disorder (HP:0003680) | 1.63460791 |
162 | Postaxial hand polydactyly (HP:0001162) | 1.63027446 |
163 | Hip dysplasia (HP:0001385) | 1.62112083 |
164 | Spondylolisthesis (HP:0003302) | 1.62086359 |
165 | Postaxial foot polydactyly (HP:0001830) | 1.60871629 |
166 | Abnormality of the intervertebral disk (HP:0005108) | 1.60528578 |
167 | Small epiphyses (HP:0010585) | 1.59325066 |
Rank | Gene Set | Z-score |
---|---|---|
1 | FRK | 5.87903068 |
2 | FGFR2 | 3.50977297 |
3 | MAP4K2 | 3.36190025 |
4 | MAP3K13 | 3.04075103 |
5 | PRPF4B | 2.88153619 |
6 | SIK3 | 2.82317213 |
7 | ERBB3 | 2.72398127 |
8 | TRIM28 | 2.67519312 |
9 | MAP3K14 | 2.51206399 |
10 | CASK | 2.25513269 |
11 | STK24 | 2.22787926 |
12 | TAOK3 | 2.06601644 |
13 | BMPR2 | 1.98813315 |
14 | FES | 1.94086389 |
15 | MAP2K7 | 1.89409622 |
16 | MAP3K4 | 1.81371256 |
17 | TXK | 1.80799119 |
18 | ARAF | 1.74410810 |
19 | ACVR1B | 1.71942932 |
20 | NUAK1 | 1.67603853 |
21 | MAP3K12 | 1.67493673 |
22 | EPHA4 | 1.61879922 |
23 | BMPR1B | 1.59648757 |
24 | MKNK2 | 1.59485161 |
25 | CDK8 | 1.59240433 |
26 | PLK2 | 1.59175318 |
27 | NEK9 | 1.53359560 |
28 | FGFR3 | 1.49600509 |
29 | MAPK13 | 1.43973631 |
30 | EIF2AK3 | 1.43800822 |
31 | GRK1 | 1.43178886 |
32 | MARK1 | 1.38832367 |
33 | BCR | 1.38094921 |
34 | JAK3 | 1.36203246 |
35 | CDK19 | 1.28758732 |
36 | MUSK | 1.24828765 |
37 | PAK3 | 1.23526394 |
38 | TNIK | 1.16431150 |
39 | MAP4K1 | 1.14192457 |
40 | NLK | 1.12936728 |
41 | NTRK3 | 1.12302939 |
42 | RIPK4 | 1.11086727 |
43 | CSNK1A1L | 1.10594597 |
44 | PNCK | 1.09758566 |
45 | AKT3 | 1.08826402 |
46 | PINK1 | 1.07838942 |
47 | YES1 | 1.06267786 |
48 | CSNK1G2 | 1.04916961 |
49 | STK39 | 1.04641216 |
50 | SGK494 | 1.04067240 |
51 | SGK223 | 1.04067240 |
52 | SGK2 | 1.04060495 |
53 | MARK3 | 1.03657655 |
54 | EPHA3 | 1.02943910 |
55 | OXSR1 | 1.02724800 |
56 | MAP3K6 | 0.99763105 |
57 | BRD4 | 0.97496885 |
58 | CSNK1G3 | 0.94419850 |
59 | KSR1 | 0.92876684 |
60 | MKNK1 | 0.92027276 |
61 | INSRR | 0.91992844 |
62 | CCNB1 | 0.91906839 |
63 | STK38L | 0.91094276 |
64 | MAP3K9 | 0.90313440 |
65 | EIF2AK1 | 0.88655538 |
66 | CAMKK2 | 0.88529116 |
67 | ZAK | 0.82723067 |
68 | SRPK1 | 0.81784240 |
69 | BCKDK | 0.81730600 |
70 | PRKCQ | 0.81370027 |
71 | PRKCG | 0.79386443 |
72 | MST4 | 0.78477742 |
73 | LCK | 0.76024542 |
74 | IRAK1 | 0.75758092 |
75 | MINK1 | 0.73988371 |
76 | IKBKB | 0.72056022 |
77 | PLK3 | 0.71289783 |
78 | SYK | 0.70995618 |
79 | PKN1 | 0.70228410 |
80 | BRSK2 | 0.69969093 |
81 | STK3 | 0.69781936 |
82 | DYRK3 | 0.69573979 |
83 | WNK4 | 0.67435145 |
84 | DMPK | 0.66557295 |
85 | PHKG1 | 0.66461600 |
86 | PHKG2 | 0.66461600 |
87 | VRK1 | 0.62920431 |
88 | JAK1 | 0.61801239 |
89 | FGR | 0.61228577 |
90 | DYRK1A | 0.60940643 |
91 | FER | 0.60106324 |
92 | RAF1 | 0.59897639 |
93 | TSSK6 | 0.59303525 |
94 | TRPM7 | 0.59088803 |
95 | IKBKE | 0.58942335 |
96 | PRKCH | 0.56620812 |
97 | PTK2B | 0.55868961 |
98 | PRKCE | 0.55093817 |
99 | IRAK4 | 0.54977622 |
100 | KSR2 | 0.52964166 |
101 | MAPKAPK5 | 0.52698770 |
102 | CSNK1G1 | 0.52491990 |
103 | SGK3 | 0.52178260 |
104 | LYN | 0.51133104 |
105 | CDK5 | 0.50580968 |
106 | CDK3 | 0.48395254 |
107 | MAP2K4 | 0.48357661 |
108 | CAMK2A | 0.48038639 |
109 | WNK3 | 0.47806918 |
110 | WNK1 | 0.47358173 |
111 | DYRK2 | 0.45360216 |
112 | NEK6 | 0.44242119 |
113 | ADRBK2 | 0.43883759 |
114 | IRAK2 | 0.43736297 |
115 | CAMK2B | 0.42948059 |
116 | GRK7 | 0.41651837 |
117 | RPS6KA4 | 0.41606927 |
118 | FGFR1 | 0.41425447 |
119 | ITK | 0.41263733 |
120 | TGFBR1 | 0.41139507 |
121 | PLK4 | 0.40493629 |
122 | DAPK2 | 0.39411078 |
123 | CHUK | 0.38586989 |
124 | ERBB4 | 0.38156807 |
125 | PASK | 0.38119860 |
126 | SGK1 | 0.37782045 |
127 | PRKG1 | 0.37202648 |
128 | TEC | 0.36863891 |
129 | PIK3CG | 0.36202564 |
130 | LIMK1 | 0.35296637 |
131 | ATM | 0.34912718 |
132 | NTRK2 | 0.34639582 |
133 | TYK2 | 0.34613596 |
134 | PLK1 | 0.34178060 |
135 | PRKACA | 0.33752186 |
136 | CSNK1D | 0.33338273 |
137 | ADRBK1 | 0.33245152 |
138 | TIE1 | 0.33117170 |
139 | NEK1 | 0.32616989 |
140 | DAPK1 | 0.32543603 |
141 | PRKACB | 0.32140410 |
142 | STK16 | 0.32027952 |
143 | CSNK1A1 | 0.31965781 |
144 | CAMK2D | 0.31044039 |
145 | HIPK2 | 0.30860703 |
146 | SIK2 | 0.30021093 |
147 | ROCK1 | 0.27834050 |
148 | HCK | 0.26679768 |
149 | BRAF | 0.26094625 |
150 | OBSCN | 0.26072454 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.41334507 |
2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.01614224 |
3 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.93352324 |
4 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54079660 |
5 | Protein export_Homo sapiens_hsa03060 | 2.50972499 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.37354017 |
7 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.27742028 |
8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.16543813 |
9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.16403028 |
10 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 2.14983580 |
11 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.08014317 |
12 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.89699671 |
13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.81545456 |
14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.79616136 |
15 | Circadian rhythm_Homo sapiens_hsa04710 | 1.77114084 |
16 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.73748072 |
17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.72452324 |
18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.70892314 |
19 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.59313421 |
20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.58239497 |
21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.53166086 |
22 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.51892960 |
23 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.50937131 |
24 | RNA degradation_Homo sapiens_hsa03018 | 1.46685314 |
25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45263460 |
26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41935740 |
27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.40557319 |
28 | Peroxisome_Homo sapiens_hsa04146 | 1.39515199 |
29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.38397737 |
30 | Phototransduction_Homo sapiens_hsa04744 | 1.37299580 |
31 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34428481 |
32 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34021394 |
33 | Morphine addiction_Homo sapiens_hsa05032 | 1.32898246 |
34 | Phagosome_Homo sapiens_hsa04145 | 1.30790620 |
35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.29690858 |
36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.27170071 |
37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.26551474 |
38 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23369182 |
39 | Allograft rejection_Homo sapiens_hsa05330 | 1.22268697 |
40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.21513164 |
41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.19111956 |
42 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.17706766 |
43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17373528 |
44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.15682015 |
45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15303945 |
46 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.14561459 |
47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14470331 |
48 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.14455385 |
49 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.14182868 |
50 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.13537338 |
51 | Homologous recombination_Homo sapiens_hsa03440 | 1.13163992 |
52 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12304013 |
53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.12112746 |
54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.12100068 |
55 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.11572752 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11523319 |
57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09165047 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.07653727 |
59 | Nicotine addiction_Homo sapiens_hsa05033 | 1.06749626 |
60 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06639269 |
61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02489135 |
62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.01004733 |
63 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.99840250 |
64 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.99611390 |
65 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99091304 |
66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.99056202 |
67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96938790 |
68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96858648 |
69 | Legionellosis_Homo sapiens_hsa05134 | 0.96813188 |
70 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.96498779 |
71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96472902 |
72 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.93330944 |
73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.93231921 |
74 | Pertussis_Homo sapiens_hsa05133 | 0.92312153 |
75 | Measles_Homo sapiens_hsa05162 | 0.91424121 |
76 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.89440215 |
77 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87923139 |
78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.87838888 |
79 | Shigellosis_Homo sapiens_hsa05131 | 0.86226897 |
80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.85414040 |
81 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83646355 |
82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81914930 |
83 | Salmonella infection_Homo sapiens_hsa05132 | 0.81909492 |
84 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.81656434 |
85 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.81542858 |
86 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.81322658 |
87 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79820345 |
88 | Tuberculosis_Homo sapiens_hsa05152 | 0.79818560 |
89 | Taste transduction_Homo sapiens_hsa04742 | 0.79774790 |
90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79648118 |
91 | Prostate cancer_Homo sapiens_hsa05215 | 0.79102962 |
92 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.78783752 |
93 | Long-term depression_Homo sapiens_hsa04730 | 0.78589218 |
94 | Alcoholism_Homo sapiens_hsa05034 | 0.77454637 |
95 | Axon guidance_Homo sapiens_hsa04360 | 0.76830140 |
96 | Hepatitis C_Homo sapiens_hsa05160 | 0.76750523 |
97 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.76339071 |
98 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.76040237 |
99 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.75523083 |
100 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75122280 |
101 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.74193369 |
102 | Asthma_Homo sapiens_hsa05310 | 0.73554698 |
103 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73444680 |
104 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72753369 |
105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72226946 |
106 | Insulin secretion_Homo sapiens_hsa04911 | 0.71005597 |
107 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.70418956 |
108 | Glioma_Homo sapiens_hsa05214 | 0.70142847 |
109 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69942208 |
110 | Renin secretion_Homo sapiens_hsa04924 | 0.69936276 |
111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69838537 |
112 | ABC transporters_Homo sapiens_hsa02010 | 0.69493671 |
113 | Hepatitis B_Homo sapiens_hsa05161 | 0.69366500 |
114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.68787494 |
115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.68473391 |
116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68317965 |
117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.67749436 |
118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67093109 |
119 | RNA polymerase_Homo sapiens_hsa03020 | 0.66946214 |
120 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66429377 |
121 | Influenza A_Homo sapiens_hsa05164 | 0.66018791 |
122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64860728 |
123 | Malaria_Homo sapiens_hsa05144 | 0.62829005 |
124 | Apoptosis_Homo sapiens_hsa04210 | 0.61747993 |
125 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61438510 |
126 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.61327236 |
127 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61023467 |
128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.60978212 |
129 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60426877 |
130 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60139325 |
131 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.59970897 |
132 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59454925 |
133 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.59163900 |
134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58570786 |
135 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58144524 |
136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57281119 |
137 | Melanoma_Homo sapiens_hsa05218 | 0.57145975 |
138 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.56878987 |
139 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56211016 |
140 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.55752042 |
141 | Proteasome_Homo sapiens_hsa03050 | 0.55736118 |
142 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55592406 |
143 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.54182774 |
144 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.51581527 |
145 | Metabolic pathways_Homo sapiens_hsa01100 | 0.49760400 |
146 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.48202863 |
147 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48079210 |
148 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47228644 |
149 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47101549 |
150 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.46498449 |
151 | Salivary secretion_Homo sapiens_hsa04970 | 0.45640575 |
152 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.44131077 |
153 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43023283 |
154 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.41019076 |
155 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.40255755 |
156 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.39134842 |
157 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.39067259 |
158 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38667348 |
159 | Purine metabolism_Homo sapiens_hsa00230 | 0.37843440 |
160 | RNA transport_Homo sapiens_hsa03013 | 0.36604460 |
161 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36498563 |
162 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.35508605 |
163 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.34054378 |
164 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.33000334 |
165 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.26317147 |
166 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25900601 |